Literature DB >> 23813219

Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy.

Jicheng Lv1, Wanyin Hou, Xujie Zhou, Gang Liu, Fude Zhou, Na Zhao, Ping Hou, Minghui Zhao, Hong Zhang.   

Abstract

Risk alleles at genome loci containing phospholipase A2 receptor 1 (PLA2R1) and HLA-DQA1 closely associate with idiopathic membranous nephropathy (IMN) in the European population, but it is unknown whether a similar association exists in the Chinese population and whether high-risk alleles promote the development of anti-PLA2R antibodies. Here, we genotyped 2132 Chinese individuals, including 1112 patients with IMN and 1020 healthy controls, for three single nucleotide polymorphisms (SNPs) within PLA2R1 and three SNPs within HLA genes. We also selected 71 patients, with varying genotypes, to assess for circulating anti-PLA2R antibody and for PLA2R expression in glomeruli. Three SNPs within PLA2R1 and one SNP within HLA-DQA1 strongly associated with IMN, and we noted gene-gene interactions involving these SNPs. Furthermore, these risk alleles strongly associated with the presence of anti-PLA2R antibodies and glomerular PLA2R expression. Among individuals who carried risk alleles for both genes, 73% had anti-PLA2R antibodies and 75% expressed PLA2R in glomeruli. In contrast, among individuals who carried protective genotypes of both genes, none had anti-PLA2R antibodies and glomerular expression of PLA2R was weak or absent. In conclusion, the interaction between PLA2R1 and HLA-DQA1 risk alleles associates with the development of IMN in the Chinese population. Individuals carrying risk alleles are predisposed to the generation of circulating anti-PLA2R autoantibodies, which may contribute to the development of IMN.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23813219      PMCID: PMC3736719          DOI: 10.1681/ASN.2012080771

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  19 in total

1.  An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis.

Authors:  Elion Hoxha; Sigrid Harendza; Gunter Zahner; Ulf Panzer; Oliver Steinmetz; Kai Fechner; Udo Helmchen; Rolf A K Stahl
Journal:  Nephrol Dial Transplant       Date:  2011-06-01       Impact factor: 5.992

2.  The renal histopathological spectrum of patients with nephrotic syndrome: an analysis of 1523 patients in a single Chinese centre.

Authors:  Fu-de Zhou; Hai-Yan Shen; Min Chen; Gang Liu; Wan-Zhong Zou; Ming-Hui Zhao; Hai-Yan Wang
Journal:  Nephrol Dial Transplant       Date:  2011-04-22       Impact factor: 5.992

3.  Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies.

Authors:  Hanna Debiec; Vincent Guigonis; Béatrice Mougenot; Fabrice Decobert; Jean-Philippe Haymann; Albert Bensman; Georges Deschênes; Pierre M Ronco
Journal:  N Engl J Med       Date:  2002-06-27       Impact factor: 91.245

Review 4.  The pathogenesis of membranous nephropathy: evolution and revolution.

Authors:  Richard J Glassock
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

5.  Membranous glomerulonephritis. Evolution of clinical and pathologic features.

Authors:  M C Gluck; G Gallo; J Lowenstein; D S Baldwin
Journal:  Ann Intern Med       Date:  1973-01       Impact factor: 25.391

Review 6.  Advances in membranous nephropathy: success stories of a long journey.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-07       Impact factor: 2.557

7.  Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Laurence H Beck; David M Beck; Jack F Wetzels; David J Salant
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-07       Impact factor: 8.237

8.  Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.

Authors:  Elion Hoxha; Ursula Kneißler; Gesa Stege; Gunther Zahner; Ina Thiele; Ulf Panzer; Sigrid Harendza; Udo M Helmchen; Rolf A K Stahl
Journal:  Kidney Int       Date:  2012-06-06       Impact factor: 10.612

9.  Experimental glomerulonephritis in the isolated perfused rat kidney.

Authors:  W G Couser; D R Steinmuller; M M Stilmant; D J Salant; L M Lowenstein
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

10.  Survival in idiopathic membranous glomerulonephritis.

Authors:  E Honkanen
Journal:  Clin Nephrol       Date:  1986-03       Impact factor: 0.975

View more
  65 in total

Review 1.  Morphology in the Digital Age: Integrating High-Resolution Description of Structural Alterations With Phenotypes and Genotypes.

Authors:  Cynthia C Nast; Kevin V Lemley; Jeffrey B Hodgin; Serena Bagnasco; Carmen Avila-Casado; Stephen M Hewitt; Laura Barisoni
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

2.  Can genetics risk-stratify patients with membranous nephropathy?

Authors:  Andrew S Bomback; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

Review 3.  Changing the concepts of immune-mediated glomerular diseases through proteomics.

Authors:  Dawn J Caster; Liliane Hobeika; Jon B Klein; David W Powell; Kenneth R McLeish
Journal:  Proteomics Clin Appl       Date:  2015-06-17       Impact factor: 3.494

4.  Genetic Complexities of the HLA Region and Idiopathic Membranous Nephropathy.

Authors:  Nikol Mladkova; Krzysztof Kiryluk
Journal:  J Am Soc Nephrol       Date:  2017-04-10       Impact factor: 10.121

Review 5.  Treatment of membranous nephropathy: time for a paradigm shift.

Authors:  Piero Ruggenenti; Fernando C Fervenza; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

6.  Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype.

Authors:  Shigeo Hara; Shunsuke Goto; Nozomu Kamiura; Akihiro Yoshimoto; Takayuki Naito; Naoko Imagawa; Yukihiro Imai; Motoko Yanagita; Shinichi Nishi; Tomoo Itoh
Journal:  Virchows Arch       Date:  2015-03-28       Impact factor: 4.064

7.  Analysis of PLA2R1 and HLA-DQA1 sequence variants in Japanese patients with idiopathic and secondary membranous nephropathy.

Authors:  Hajime Kaga; Atsushi Komatsuda; Ayumi Omokawa; Shin Okuyama; Kensuke Mori; Hideki Wakui; Naoto Takahashi
Journal:  Clin Exp Nephrol       Date:  2017-08-28       Impact factor: 2.801

Review 8.  Novel biomarkers in glomerular disease.

Authors:  Yasar Caliskan; Krzysztof Kiryluk
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

Review 9.  Insights into kidney diseases from genome-wide association studies.

Authors:  Matthias Wuttke; Anna Köttgen
Journal:  Nat Rev Nephrol       Date:  2016-08-01       Impact factor: 28.314

10.  MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy.

Authors:  Zhao Cui; Li-Jun Xie; Fang-Jin Chen; Zhi-Yong Pei; Li-Jie Zhang; Zhen Qu; Jing Huang; Qiu-Hua Gu; Yi-Miao Zhang; Xin Wang; Fang Wang; Li-Qiang Meng; Gang Liu; Xu-Jie Zhou; Li Zhu; Ji-Cheng Lv; Fan Liu; Hong Zhang; Yun-Hua Liao; Lu-Hua Lai; Pierre Ronco; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2016-11-16       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.